Lamisil AT
This article was originally published in The Tan Sheet
Executive Summary
Novartis antifungal carries twice-a-day dosing for athlete's foot, not once-a-day, as reported in 1"The Tan Sheet" March 18, 2002, p. 15. Lamisil does carry a once-a-day dosing schedule for jock itch, ringworm. Schering-Plough's new Lotrimin Ultra is only OTC athlete's foot treatment to bear once-a-day dosing regimen...
You may also be interested in...
Schering Lotrimin Ultra Is “Ultra Powerful. Ultra Easy,” Ads State
Television ads for Schering-Plough's Lotrimin Ultra Antifungal Cream for both athlete's foot and jock itch highlight the ease and power of the product's "once-a-day" application and prescription strength ingredient
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.